Jim Simons Immuno Gen, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.46 - $29.95 $11.2 Million - $26.9 Million	896,600 Added 122.05%	1,631,240 $48.4 Million
Q3 2023 Nov 14, 2023	SELL	$14.09 - $19.87 $6.81 Million - $9.61 Million	-483,400 Reduced 39.69%	734,640 $11.7 Million
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $4.27 Million - $22.8 Million	1,138,900 Added 1439.1%	1,218,040 $23 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $290,443 - $389,368	79,140 New	79,140 $304,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $1.15 Million - $1.66 Million	256,400 Added 17.7%	1,705,140 $8.15 Million
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $42,840 - $78,336	-13,600 Reduced 0.93%	1,448,740 $6.52 Million
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $1.04 Million - $1.83 Million	244,953 Added 20.12%	1,462,340 $6.96 Million
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $358,848 - $566,602	75,547 Added 6.62%	1,217,387 $9.03 Million
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $4.73 Million - $6.21 Million	-942,250 Reduced 45.21%	1,141,840 $6.47 Million
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $1.28 Million - $1.9 Million	220,750 Added 11.85%	2,084,090 $13.7 Million
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $15.4 Million - $25 Million	-2,372,626 Reduced 56.01%	1,863,340 $15.1 Million
Q4 2020 Feb 10, 2021	SELL	$3.7 - $7.66 $8.34 Million - $17.3 Million	-2,253,173 Reduced 34.72%	4,235,966 $27.3 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $11 Million - $15.5 Million	-3,176,000 Reduced 32.86%	6,489,139 $23.4 Million
Q2 2020 Aug 13, 2020	SELL	$3.32 - $5.34 $4.49 Million - $7.21 Million	-1,350,990 Reduced 12.26%	9,665,139 $44.5 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $655,058 - $2.1 Million	308,990 Added 2.89%	11,016,129 $37.6 Million
Q4 2019 Feb 13, 2020	BUY	$2.25 - $5.8 $4.91 Million - $12.7 Million	2,184,100 Added 25.63%	10,707,139 $54.7 Million
Q3 2019 Nov 13, 2019	BUY	$2.22 - $3.39 $3.55 Million - $5.43 Million	1,600,399 Added 23.12%	8,523,039 $20.6 Million
Q2 2019 Aug 12, 2019	SELL	$1.8 - $3.3 $217,800 - $399,300	-121,000 Reduced 1.72%	6,922,640 $15 Million
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $2.08 Million - $5.09 Million	861,500 Added 13.94%	7,043,640 $19.1 Million
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $24.4 Million - $60 Million	6,182,140 New	6,182,140 $29.7 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account